Associated Papers
Survival in a Contemporary, Real-World Cohort of Patients with Mixed-Phenotype Transthyretin Amyloid Cardiomyopathy Treated with Tafamidis: An Analysis from THAOS.
Wixner J et al.
Cardiology and Therapy, 2025
Survival in a Real-World Cohort of Patients With Transthyretin Amyloid Cardiomyopathy Treated With Tafamidis: An Analysis From the Transthyretin Amyloidosis Outcomes Survey (THAOS).
Garcia-Pavia P et al.
Journal of Cardiac Failure, 2025
A 15-year consolidated overview of data in over 6000 patients from the Transthyretin Amyloidosis Outcomes Survey (THAOS).
Gentile L et al.
Orphanet Journal of Rare Diseases, 2023
37946256 (PubMed )
Supplement: 13023_2023_2962_MOESM1_ESM.docx
Serum Proteomic Variability Associated with Clinical Phenotype in Familial Transthyretin Amyloidosis (ATTRm).
Chan GG et al.
Journal of Proteome Research, 2017
Differential post-translational modifications of transthyretin in Alzheimer's disease: a study of the cerebral spinal fluid.
Biroccio A et al.
Proteomics, 2006
Haplotypes and DNA sequence variation within and surrounding the transthyretin gene: genotype-phenotype correlations in familial amyloid polyneuropathy (V30M) in Portugal and Sweden.
Soares ML et al.
European Journal of Human Genetics : Ejhg, 2004
Select a paper to view details